Poseida Therapeutics, Inc.

Q4 2023 13F Holders

Symbol
PSTX
CUSIP
73730P108
Type
Equity
Class
COM
Num filings
96
Total reported value, excl. options
$155 M
Manager Report Date Value ($000) Shares Option Type